Jonathan Metts

11PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Adolescent healthCancer geneticsMechanobiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 06, 2026
Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

|Oct 15, 2025
A Phase I Trial of Nab-Paclitaxel in Combination With Gemcitabine for Relapsed/Refractory Pediatric Solid Tumors.

Jonathan Metts, Kevin Ginn, Zhulin He

|Jun 23, 2025
Adolescent and Young Adult Oncology in the United States in 2025: Finding Its Place in the Oncology World-Part 1 of 2.

Peter H Shaw, Sharon M Castellino, Jonathan Metts

|Oct 03, 2024
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.

Aditi Dhir, Masanori Hayashi, Avery Bodlak

|Jul 20, 2024
Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib.

Isaac Hauk, Ignacio Gonzalez-Gomes, Deepak Chellapandian

|Jun 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane

Pageof 2

Frequent Collaborators

2 joint publications

Samer Sansil

2 joint publications

Damon Reed

2 joint publications

Sapna Oberoi

2 joint publications

Roshni Dasgupta